A packet of envelopes <a href=" http://www.potawatomiheritage.org/generic-drugs-etf.pdf#individual ">health pharmacy online reviews</a> Roche Holding AG could buy the maker of drugs forrare diseases for about $95 to $105 per share in a deal valuedat about $15 billion, media reports said, quotingdealreporter.com. UBS AG will lend $5 billion to Rochefor the takeover, the reports quoted dealreporter.com as saying.
|